ISAC is now accepting Project Grant applications to fund antimicrobial research in low- to middle- income countries from ISAC Member Society applicants**

Applications are invited for grants between £5,000 and £10,000.

Aim of Research Project

Applicants are required to demonstrate that ISAC funds will be utilised for a clearly defined piece of research, which will have an identifiable outcome on completion of the work. At least one country involved must be a low- to middle- income country.

Research projects should address one of the three following areas:

  • What are feasible and effective prevention strategies to prevent transmission of (resistant) pathogens in low resource settings?
  • What basic laboratory support does a healthcare system minimally need to tackle infectious diseases?
  • How do we improve antimicrobial use worldwide to ensure it is delivered only to those who need it?

Project Criteria

  • Projects can last up to 24 months.
  • 6-monthly updates are required.
  • Funds can be used for staff or materials.
  • At least two institutions should be involved in the project of which at least one is from a low- or middle-income country.

Eligibility of applicants

  • Principal applicant must be a member of an ISAC Member Society. Visit the website to see the full list of ISAC Member Societies.
  • Other applicants do not need to be a member of an ISAC Member Society.
  • The principal applicant must be the principal investigator on the intended research.
  • At least one country involved must be a low- to middle- income country.

The deadline to submit is 1 September 2021
(but earlier applications are advised)

Visit the website for more information on how to apply.

**If you are not a member of an ISAC Member Society but are a member of another relevant society, the society can join ISAC for free by emailing Bu e-Posta adresi istenmeyen posta engelleyicileri tarafından korunuyor. Görüntülemek için JavaScript etkinleştirilmelidir..

ISAC unites infectious disease and microbiology societies around the world.